TY  - GEN
AU  - Barnett,Christopher F
AU  - Bonura,Eric J
AU  - Nathan,Steven D
AU  - Ahmad,Shahzad
AU  - Shlobin,Oksana A
AU  - Osei,Kwabena
AU  - Zaiman,Ari L
AU  - Hassoun,Paul M
AU  - Moller,David R
AU  - Barnett,Scott D
AU  - Girgis,Reda E
TI  - Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience
SN  - 1931-3543
PY  - 2009///0707
KW  - Administration, Inhalation
KW  - Administration, Oral
KW  - Aged
KW  - Antihypertensive Agents
KW  - administration & dosage
KW  - Bosentan
KW  - Cohort Studies
KW  - Drug Therapy, Combination
KW  - Epoprostenol
KW  - Female
KW  - Follow-Up Studies
KW  - Hemodynamics
KW  - drug effects
KW  - Humans
KW  - Hypertension, Pulmonary
KW  - drug therapy
KW  - Iloprost
KW  - Kaplan-Meier Estimate
KW  - Linear Models
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Probability
KW  - Purines
KW  - Respiratory Function Tests
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Sarcoidosis
KW  - complications
KW  - Severity of Illness Index
KW  - Sildenafil Citrate
KW  - Statistics, Nonparametric
KW  - Sulfonamides
KW  - Sulfones
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Intramural
UR  - https://doi.org/10.1378/chest.08-1881
ER  -